SLC7A11 and neoplasm: Silencing of SLC7A11 expression using our siRNA nanoparticle in patient derived PDAC explants demonstrated potent anti-tumour and anti-stromal effects, and similar results were observed with sulfasalazine treatment of the patient explants [95].